| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $78.7M | +233.6% |
| SG&A Expense | $15.8M | +87.3% |
| Operating Income | -$94.5M | -195.0% |
| Interest Expense | $1.5M | — |
| Pre-tax Income | -$95.1M | -196.7% |
| Income Tax | $25K | — |
| Net Income | -$95.1M | -196.8% |
| EPS (Basic) | -$4.09 | -54.9% |
| EPS (Diluted) | -$4.09 | -54.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $45.9M | -68.6% |
| Short-term Investments | $44.4M | — |
| Current Assets | $93.0M | -37.8% |
| Total Assets | $94.2M | -37.0% |
| Current Liabilities | $15.7M | +78.5% |
| Long-term Debt | $29.4M | — |
| Total Liabilities | $45.1M | +413.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$85.5M | -183.4% |
| Capital Expenditures | $86K | — |
| Investing Cash Flow | -$44.4M | — |
| Financing Cash Flow | $29.5M | -69.6% |
| Free Cash Flow | -$85.6M | -183.7% |
| Stockholders' Equity |
| $49.0M |
| -65.2% |